Skip to content

Specimen Banking From Patients With Lung Cancer

Specimen Banking From Patients With Lung Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01585675
Enrollment
2000
Registered
2012-04-26
Start date
2005-11-03
Completion date
2035-07-01
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms

Keywords

Lung Cancer

Brief summary

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Detailed description

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

Interventions

None listed

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer. 2. Oral and written informed consent

Exclusion criteria

1\. Any individual who does not give oral and written consent for participation

Design outcomes

Primary

MeasureTime frameDescription
Development of a comprehensive specimen banking program from patients with lung cancer for future translational research.6 yearsNo statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.

Countries

United States

Contacts

CONTACTBrandi Kubala
brandi.kubala@cuanschutz.edu303-724-1657
PRINCIPAL_INVESTIGATORAdriaan VanBokhoven, PhD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026